Latest Breaking News On - Hematology association congress - Page 1 : comparemela.com

Encouraging Data Emerge for Outpatient CAR T-Cell Treatment of Lymphoma

Results presented at the 2024 European Hematology Association Congress suggest that chimeric antigen receptor (CAR) T-cell therapy can be feasibly and safely delivered in the outpatient setting as treatment for lymphoma.

SL-172154 Receives FDA Orphan Drug Designation in AML

SL-172154 has been granted orphan drug designation from the FDA in acute myeloid leukemia.

Ryvu Therapeutics to present clinical and preclinical data on RVU120 at the 2024 European Hematology Association Congress

Faron's Financial Statement Release January 1 to December 31, 2023 -March 13, 2024 at 03:01 am EDT

TURKU, Finland and BOSTON, March 13, 2024 Faron Pharmaceuticals Ltd. , a clinical-stage biopharmaceutical company focused on tackling cancers via novel myeloid cell targeted immunotherapies,.

IO-202 Receives FDA Orphan Drug Designation for CMML

The FDA has granted IO-202 an orphan drug designation for patients with chronic myelomonocytic leukemia.